logo
Plus   Neg
Share
Email

McCormick Withdraws FY20 Outlook Amid COVID-19 Outbreak - Quick Facts

While reporting financial results for the first quarter of fiscal 2020 on Tuesday, McCormick & Co., Inc. (MKC) said it is withdrawing its financial guidance for the full year 2020, previously issued on January 28, 2020, due to the uncertainty of the duration and extent of the coronavirus (COVID-19) pandemic impact.

However, the company reaffirmed its long-term financial objectives and capital allocation priorities.

The company said its first quarter results were significantly impacted by the extraordinary disruption in China's consumption related to the COVID-19 outbreak. Lower operating results from this impact offset the otherwise solid sales, operating income and earnings per share growth delivered in the first quarter.

"We plan to emerge strong from this event through driving our long-term strategies and reacting with agility to changing consumer behavior and capitalizing on opportunities from our relative strength," said Lawrence Kurzius, Chairman, President and CEO.

The company said it expects to resume guidance at the time of its second quarter earnings release in June 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT